Your browser doesn't support javascript.
loading
A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.
Wang, Haiyue; Sun, Leina; Sang, Yaxiong; Yang, Xin; Tian, Guangming; Wang, Ziping; Fang, Jian; Sun, Wei; Zhou, Lixin; Jia, Ling; Tsao, Ming-Sound; Shi, Huaiyin; Lin, Dongmei.
Afiliação
  • Wang H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Sun L; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Sang Y; Oncology Business Division, Beijing Novogene Bioinformatics Technology Co., Ltd, Beijing, People's Republic of China.
  • Yang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Tian G; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic OncologyⅡ, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Wang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic OncologyⅠ, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Fang J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic OncologyⅡ, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Sun W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Zhou L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Jia L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.
  • Tsao MS; University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada.
  • Shi H; Pathology Department, Chinese PLA General Hospital and Chinese PLA Medical School, Beijing, People's Republic of China. Electronic address: shihuaiyin@sina.com.
  • Lin D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China. Electronic address: lindm3@163.com.
Lung Cancer ; 130: 135-142, 2019 04.
Article em En | MEDLINE | ID: mdl-30885334
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Inibidores de Proteínas Quinases / Crizotinibe / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Inibidores de Proteínas Quinases / Crizotinibe / Quinase do Linfoma Anaplásico / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Irlanda